NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹33 Cr | ₹21 Cr | ₹15 Cr | ₹21 Cr | ₹14 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
Year | Short Term Loans and Advances |
---|---|
Mar2025 | ₹33 Cr |
Mar2024 | ₹21 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹14 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2025 | ₹33 Cr | 54.46 | |
Mar2024 | ₹21 Cr | 40.13 | |
Mar2023 | ₹15 Cr | -28.97 | |
Mar2022 | ₹21 Cr | 51.58 | |
Mar2021 | ₹14 Cr | - |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹872.4 Cr | 3% | 10.1% | -38.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 3% |
10.1% |
-38.9% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses